MgO NPs catalyzed the synthesis of novel pyridin-3-yl-pyrimidin-2-yl-aminophenyl-amide derivatives and evaluation of pharmacokinetic profiles and biological activity

Abstract

In this study, novel pyridin-3-yl-pyrimidin-2-yl-aminophenyl-amide derivatives using two methods, namely, using trimethylamine as a classical method and using magnesium oxide nanoparticles, were synthesized. Biological activities of the derivatives such as inhibitors of receptor tyrosine kinase, pharmacokinetics profiles, anticancer activity against lung cancer, antibacterial and antifungal activity against specialized aquatic bacterial species, Gram-positive and Gram-negative species, and fungal species, and antioxidant activity were evaluated. The structures of synthetic derivatives were confirmed using FT-IR, 1H-NMR, and 13C-NMR spectra and elemental analysis. The results showed that these compounds possess more cytotoxic activity than the reference drug (i.e., imatinib). Furthermore, compound IIB gives ten-fold lower IC50 values (0.229 μM) than imatinib (2.479 μM) when tested against (A549) lung cancer cell lines employing MTT assay. To investigate antibacterial and antifungal activities, minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC), and minimum fungicidal concentration (MFC) parameters were evaluated, and derivative IIC showed the highest activity (MIC 16–128 μg/mL), which can be attributed to its structure. In addition, the antibacterial and antifungal properties of the derivatives were higher than some drugs. The antioxidant property of the derivatives was studied by using the DPPH (2,2-diphenylpicrylhydrazyl) method, and the results showed that the evaluated IC50 value was close to the IC50 value of ascorbic acid (4.45–4.83 μg/mL).

Association between plant-based diets and metabolic syndrome in obese adults from Iran: a cross-sectional study

“…Nevertheless, increased consumption of added sugars can lead to adverse effects on weight, blood pressure, lipid metabolism, and glycemic control, particularly high dietary fructose can increase hepatic de novo lipogenesis [ 67 ]. PBDs have a low energy density and low-energy food consumption is important for weight control and can decrease the incidence of abdominal obesity [ 68 , 69 ]. Such a diet could have so several positive effects on health such as helping weight loss or maintenance, insulin regulation, improving lipid profile, and reducing blood pressure [ 17 – 19 ].…”

Graphene-based hybrid composites for cancer diagnostic and therapy

“…Poor solubility, low bioavailability, unexpected metabolization and drug elimination of the body before function on their desired sites, non-specific selectivity, and side effects are some of the drawbacks of traditional treatments [ 2 , 3 ]. However, recent advances in nanotechnology and nanomaterials could have provided a better bio-distribution of drugs, reduced adverse effects, and delivered therapeutic agents to the targeted sites, improving bioavailability [ 4 , 5 ]. In recent years, numerous organic and inorganic nanomaterials have been investigated for nanomedicine applications [ 6 – 9 ].…”